• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对从越南北部省份儿童粪便中分离出的M31进行口服毒性评估。

Oral toxicity evaluation of M31 isolated from the children's feces in the northern province of Vietnam.

作者信息

Ngo Nguyen Quynh Anh, Nguyen Huong Thi, Dam Xuan Thanh, Bui Dinh Nhi, Minh Thi Thao

机构信息

Center for Pharmaceutical Research and Business, Hai Duong Central College of Pharmacy, 324 Nguyen Luong Bang, Hai Duong City 170000, Vietnam.

Faculty of Biotechnology, Hanoi University of Pharmacy, 13-15 Le Thanh Tong, Ha Noi City 100000, Vietnam.

出版信息

Toxicol Res (Camb). 2024 Sep 24;13(5):tfae152. doi: 10.1093/toxres/tfae152. eCollection 2024 Oct.

DOI:10.1093/toxres/tfae152
PMID:39323477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11420515/
Abstract

This study investigated the acute and repeated 28-day dose toxicity profiles of M31, isolated from children's feces, in Swiss rats and New Zealand rabbits. To investigate acute toxicity, rats were given varied doses of M31 (1 × 10 CFU/mL, 3 × 10 CFU/mL, and 5 × 10 CFU/mL) orally once daily for 14 days, in accordance with OECD recommendations No. 423. To evaluate toxicity, rabbits were given either a low dosage (1 × 10 CFU/mL) or a high dose (5 × 10 CFU/mL) during a 28-day period using the OECD Test Guideline 407 protocol. Neither death nor significant abnormalities were observed in the rats during the experiment. The microscopic examination of key organs revealed no substantial changes in organ morphology. Furthermore, analyses of serum biochemistry and hematological parameters did not reveal any treatment-associated variations. In sum, these findings suggest that the oral intake of M31 at concentrations up to 5 × 10 CFU/mL for 28 days poses no discernible risks.

摘要

本研究调查了从儿童粪便中分离出的M31对瑞士大鼠和新西兰兔的急性毒性及28天重复给药毒性特征。为研究急性毒性,按照经合组织(OECD)第423号建议,大鼠每天口服一次不同剂量的M31(1×10 CFU/mL、3×10 CFU/mL和5×10 CFU/mL),持续14天。为评估毒性,根据OECD测试指南407方案,在28天期间给兔子低剂量(1×10 CFU/mL)或高剂量(5×10 CFU/mL)的M31。实验期间大鼠未出现死亡或明显异常。对关键器官的显微镜检查未发现器官形态有实质性变化。此外,血清生化和血液学参数分析未发现任何与治疗相关的差异。总之,这些结果表明,连续28天口服浓度高达5×10 CFU/mL的M31没有明显风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085a/11420515/0ebcc2f8ecb6/tfae152ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085a/11420515/0ebcc2f8ecb6/tfae152ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085a/11420515/0ebcc2f8ecb6/tfae152ga1.jpg

相似文献

1
Oral toxicity evaluation of M31 isolated from the children's feces in the northern province of Vietnam.对从越南北部省份儿童粪便中分离出的M31进行口服毒性评估。
Toxicol Res (Camb). 2024 Sep 24;13(5):tfae152. doi: 10.1093/toxres/tfae152. eCollection 2024 Oct.
2
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低人类免疫缺陷病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003510. doi: 10.1002/14651858.CD003510.pub2.
3
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
4
Amnioinfusion for chorioamnionitis.羊膜腔灌注治疗绒毛膜羊膜炎。
Cochrane Database Syst Rev. 2016 Aug 24;2016(8):CD011622. doi: 10.1002/14651858.CD011622.pub2.
5
Supplementing a Bacillus-based probiotic to high-risk stocker cattle.向高风险育肥牛补充芽孢杆菌益生菌。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae209.
6
Blood biomarkers for the non-invasive diagnosis of endometriosis.用于子宫内膜异位症无创诊断的血液生物标志物。
Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179.
7
Interventions for improving adherence to amblyopia treatments in children.改善儿童弱视治疗依从性的干预措施。
Cochrane Database Syst Rev. 2025 Jul 2;7(7):CD015820. doi: 10.1002/14651858.CD015820.pub2.
8
Nebulised hypertonic saline for cystic fibrosis.雾化高渗盐水用于囊性纤维化
Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD001506. doi: 10.1002/14651858.CD001506.pub4.
9
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043-02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial.抗结核候选药物BTZ-043在南非的安全性、杀菌活性和药代动力学研究(泛亚ACEA-BTZ-043-02):一项开放标签、剂量扩展、随机、对照的1b/2a期试验。
Lancet Microbe. 2025 Feb;6(2):100952. doi: 10.1016/j.lanmic.2024.07.015. Epub 2025 Jan 7.
10
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.

本文引用的文献

1
In-vitro and preclinical testing of UBBS-14 probiotic in rats shows no toxicity.UBBS-14益生菌在大鼠体内的体外和临床前测试显示无毒性。
Toxicol Res (Camb). 2024 Feb 22;13(1):tfae021. doi: 10.1093/toxres/tfae021. eCollection 2024 Feb.
2
In Vivo Toxicity Assessment of the Probiotic HTI-19 Isolated from Stingless Bee ( Honey.从无刺蜜蜂(蜂蜜)中分离出的益生菌 HTI-19 的体内毒性评估
Nutrients. 2023 May 19;15(10):2390. doi: 10.3390/nu15102390.
3
Current Progress and Future Perspectives on the Use of Bacillus clausii.克劳氏芽孢杆菌应用的当前进展与未来展望
Microorganisms. 2022 Jun 17;10(6):1246. doi: 10.3390/microorganisms10061246.
4
Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection.芽孢杆菌属益生菌菌株在轮状病毒感染体外模型中的保护作用。
Sci Rep. 2020 Jul 28;10(1):12636. doi: 10.1038/s41598-020-69533-7.
5
[THE GUT MICROBIOME AS A TARGET FOR PREVENTION OF ALLERGIC DISEASES].[作为预防过敏性疾病靶点的肠道微生物群]
Arerugi. 2020;69(1):19-22. doi: 10.15036/arerugi.69.19.
6
Safety and probiotic evaluation of two strains producing antioxidant compounds.两种抗氧化化合物产生菌株的安全性和益生菌评估。
Benef Microbes. 2019 Oct 14;10(7):759-771. doi: 10.3920/BM2019.0040. Epub 2019 Sep 16.
7
Safety evaluation of Bacillus coagulans SNZ 1969 in Wistar rats.凝结芽孢杆菌 SNZ1969 在 Wistar 大鼠中的安全性评价。
Regul Toxicol Pharmacol. 2020 Feb;110:104538. doi: 10.1016/j.yrtph.2019.104538. Epub 2019 Nov 18.
8
strains as human probiotics: characterization, safety, microbiome, and probiotic carrier.作为人类益生菌的菌株:特性、安全性、微生物组及益生菌载体
Food Sci Biotechnol. 2019 Oct 8;28(5):1297-1305. doi: 10.1007/s10068-019-00691-9. eCollection 2019 Oct.
9
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2019 Apr 30;4(4):CD004827. doi: 10.1002/14651858.CD004827.pub5.
10
Safety assesment of UBBC07, a spore forming probiotic.芽孢形成益生菌UBBC07的安全性评估
Toxicol Rep. 2017 Jan 5;4:62-71. doi: 10.1016/j.toxrep.2016.12.004. eCollection 2017.